Search research articles
Contact Us
Filters
Showing results (481-490 of 522) with videos related to
Page
of 53
Sort By:
Lancet (London, England)
|
December 25, 2010
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data
M P Coleman, D Forman, H Bryant, et al.
Trials
|
August 7, 2019
Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan
Serigne N Lo, Angela M Hong, Lauren E Haydu, et al.
British Journal of Cancer
|
March 2, 2013
Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study
S Walters, C Maringe, J Butler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 12, 2025
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients
Takami Sato, Marcus O Butler, Sophie Piperno-Neumann, et al.
Journal of Dairy Science
|
December 21, 2022
Selective treatment of nonsevere clinical mastitis does not adversely affect cure, somatic cell count, milk yield, recurrence, or culling: A systematic review and meta-analysis
Ellen de Jong, Lien Creytens, Sarne De Vliegher, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 4, 2020
Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'
Ketty Peris, Maria C Fargnoli, Claus Garbe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 26, 2020
Response to: Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'
Ketty Peris, Maria C Fargnoli, Claus Garbe, et al.
Future Oncology (London, England)
|
March 31, 2026
Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma
Reinhard Dummer, Shahneen Sandhu, Wilson H Miller, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 10, 2019
Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines
Ketty Peris, Maria Concetta Fargnoli, Claus Garbe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2025
Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma
Reinhard Dummer, Shahneen Sandhu, Wilson H Miller, et al.
Page
of 53
Search research articles
Search
Showing results (481-490 of 522) with videos related to
Sort By:
Page
of 53
Lancet (London, England)
|
December 25, 2010
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data
M P Coleman, D Forman, H Bryant, et al.
Trials
|
August 7, 2019
Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan
Serigne N Lo, Angela M Hong, Lauren E Haydu, et al.
British Journal of Cancer
|
March 2, 2013
Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study
S Walters, C Maringe, J Butler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 12, 2025
Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 Patients
Takami Sato, Marcus O Butler, Sophie Piperno-Neumann, et al.
Journal of Dairy Science
|
December 21, 2022
Selective treatment of nonsevere clinical mastitis does not adversely affect cure, somatic cell count, milk yield, recurrence, or culling: A systematic review and meta-analysis
Ellen de Jong, Lien Creytens, Sarne De Vliegher, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 4, 2020
Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'
Ketty Peris, Maria C Fargnoli, Claus Garbe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 26, 2020
Response to: Comment on 'Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines'
Ketty Peris, Maria C Fargnoli, Claus Garbe, et al.
Future Oncology (London, England)
|
March 31, 2026
Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma
Reinhard Dummer, Shahneen Sandhu, Wilson H Miller, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 10, 2019
Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines
Ketty Peris, Maria Concetta Fargnoli, Claus Garbe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2025
Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma
Reinhard Dummer, Shahneen Sandhu, Wilson H Miller, et al.
Page
of 53